Body Weight at Age Four Years and Readiness to Start School: A Prospective Cohort Study
Jessica Omand(Target (United States)), Douglas Campbell, Laura N. Anderson(Impact), Jonathon L. Maguire(St. Michael's Hospital), Mark S. Tremblay(Children's Hospital of Eastern Ontario), Hakimat Shaibu, Ashna Bowry(McMaster University), Imaan Bayoumi(Target (United States)), Patricia C. Parkin(Hospital for Sick Children), Caroline Calpin, Marivic Bustos, Tony Barozzino, Kardelen Kurt, Mateenah Jaleel, Michelle Mitchell(Target (United States)), Joey Bonifacio, Gordon Arbess, Charles Keown‐Stoneman(St. Michael's Hospital), Amanda Offord, Natricha Levy McFarlane, Eric Duku(McMaster University), Dana Arafeh, Martin Ogwuru, Magdalena Janus(Target (United States)), Muhammad Mamdani(Unity Health Toronto), Patricia Raso, Jillian G. Baker(Nottingham University Hospitals NHS Trust), Gerald Lebovic(St. Michael's Hospital), Caroline Reid‐Westoby(McMaster University), Cornelia M. Borkhoff(University of Ottawa), Ataat Malick(University of Toronto), Laurie Thompson, Gary Bloch, Pamela Ruth Flores, Xuedi Li(Target (United States)), Julia Thompson, Nav Persaud(St Michael’s Hospital), M. B. Abdurrahman, Janis Randall Simpson(University of Guelph), Peter J. Wong, Pat Parkin(Target (United States)), Catherine S. Birken(University of Toronto), Sylvie Bergeron, Yulika Yoshida‐Montezuma(Impact), Sharon Thadani(Target (United States)), Patricia Li(Target (United States))
Cited by 5
Related Papers
Systematic review of the relationships between objectively measured physical activity and health indicators in school-aged children and youth
|Applied Physiology Nutrition and Metabolism|2016|2.2k
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
Global Matrix 3.0 Physical Activity Report Card Grades for Children and Youth: Results and Analysis From 49 Countries
|Journal of Physical Activity and Health|2018|820
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586